CVS HEALTH Corp
NYSE: CVS·Woonsocket, Rhode Island·CIK 0000064803
- Price
- $88.59
- Base IV
- $232.05
Valuation snapshot
At $88.59, the price is below even our bear case of $135.83.
Values per share, from an .
- No growth
- …
- Loading earnings power
- Base case
- $232.05
- above today's price · range $135.83–$366.46
- Price vs base case
- 62% below
- $88.59 against $232.05
- Base case · our researched forecast, 2026-11-05See the research ↗
- Price vs base · derived: price − base caseWhat the price expects ↗
- Price · StockValuer price feed, 2026-11-16 closeno link today
The price has risen 10.8% since this valuation was struck on 2026-11-05, so some of the gap opened up after these figures were set.
Whisker on the base case runs bear $135.83 to bull $366.46. Values per share.
Price against each value
- Bear case
- $135.83
- Price 35% below
- No growth
- …
- —
- Base case
- $232.05
- Price 62% below
What does CVS Health do?
CVS Health provides health insurance, pharmacy benefits management, and retail pharmacy services to help individuals and employers manage medical costs and access healthcare services.
It brought in $420.6B of sales in the 12 months to Sep 2026.
Led by David Joyner, President and Chief Executive Officer since 2024. CVS Health Corporation Form 10-K
- Industry
- Consumer staples
- Based in
- Woonsocket, Rhode Island
- Trades on
- NYSE as CVS
Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Sep 2026, about 3¢ was left as profit after every cost, interest and tax. The biggest cost is making what it sells, 56¢ of every dollar.
- Making what it sells56¢
- Everything else it takes to operate41¢
- Interest and other costs1¢
- Left as profit3¢
Who pays CVS Health, and for what?
CVS Health runs Aetna health insurance, the CVS Caremark pharmacy benefits business and about 9,000 CVS Pharmacy stores. It makes money from insurance premiums, from selling and managing prescription drugs for employers and health plans, and from store sales of medicines and everyday products. It also runs clinics and in-home health checks.
Employers, individuals, health plans and the US government pay it; federal government payments made up about 20% of total 2025 revenue, mostly through Medicare.
Health Services (CVS Caremark, clinics)
Manages prescription drug benefits for about 87 million plan members and runs mail-order and specialty pharmacies, Oak Street Health primary care centers, MinuteClinic and Signify Health in-home checks. Segment figures include sales to other CVS units, so the three shares add up to more than 100%.
Health Care Benefits (Aetna)
Health insurance for more than 37 million people through employers, Medicare Advantage, Medicare drug plans, Medicare Supplement and Medicaid. Most of this money comes from premiums. 2025 revenue was $143.4 billion.
Pharmacy & Consumer Wellness (CVS Pharmacy stores)
About 9,000 stores that filled 1.8 billion prescriptions in 2025. Prescriptions made up 82.9% of this segment's sales, and front-store items like health, beauty and household goods made up 17.1%.
Where its work physically happens, beyond headquarters:
- Health Care Benefits principal office — Hartford, United States. This 1.7 million-square-foot complex is the principal office of CVS Health's Health Care Benefits segment.
- Hainesport distribution center — Hainesport, United States. Its automated systems replenish CVS Pharmacy stores across the Northeast and Mid-Atlantic with health, beauty and personal-care products.
- Jersey City bulk distribution center — Jersey City, United States. The bulk distribution center expands supply capacity for CVS Pharmacy stores across the New York City region.
- Chemung distribution center — Chemung, United States. CVS reported that this distribution center was built to support 350 pharmacy stores in the Northeast.
- Flower Mound specialty mail pharmacy — Flower Mound, United States. This CVS Specialty mail-service pharmacy dispenses and delivers medications for patients with complex conditions.
How is the business doing?
Sales grew from $268.7B in 2020 to $402.1B in 2025, about 8% a year.
Running the business leaves about 4¢ of each sales dollar as operating profit, about the same as 5¢ in 2020.
After paying for its upkeep and new investment, it had $15.6B of cash to spare in the 12 months to Sep 2026.
What does management say it's aiming for?
CVS Health says it exists to make health care simpler for people, and it wants to be America's most trusted health care company.
“Our purpose is to simplify health care one person, one family and one community at a time.”
Who is responsible for the plan?
- David JoynerPresident and Chief Executive Officer
Oversees enterprise strategy, operations, and governance across CVS Health's integrated healthcare, pharmacy services, and benefits businesses. Directs the connected healthcare enterprise combining health insurance, pharmacy benefit management, retail pharmacy dispensing, and care delivery clinics to generate diversified revenue.
- Prem ShahExecutive Vice President and Group President
Oversees operational performance and integrated execution across Pharmacy Services, Pharmacy & Consumer Wellness, and Health Care Delivery businesses. Drives core revenue generation across pharmacy benefit management, retail prescription fulfillment, consumer wellness products, and primary care clinic operations.
- Tilak MandadiExecutive Vice President, Ventures and Chief Digital, Data, Analytics and Technology Officer
Oversees enterprise data, artificial intelligence, digital architecture, consumer technology platforms, and corporate venture investments. Develops the digital and technology infrastructure that powers patient engagement, online pharmacy services, and omnichannel consumer care delivery.
Roles checked November 14, 2026.
What management says it is working on now:
Making Aetna profitable again
Aetna's adjusted operating income fell from $5.6 billion in 2023 to $0.3 billion in 2024, then recovered to $2.9 billion in 2025. In mid-2026 the company credited its margin recovery plan for higher insurance profits and raised its 2026 outlook for the segment.
CVS Health Q2 2026 results press releaseCutting back unprofitable lines
Aetna left the individual public insurance exchanges in January 2026. The company also largely exited two Medicare cost-sharing programs for health systems in 2025, and it plans to close some Oak Street Health clinics in 2026.
CVS Health 2025 Form 10-KConnecting its businesses to lower costs
Its strategy is to simplify care, keep people more engaged, lower costs and improve health results. It does this by linking its insurer, pharmacy benefits business, stores and clinics.
CVS Health 2025 Form 10-KCheaper copies of costly drugs
Through its Cordavis unit, CVS works with drugmakers to bring lower-cost copies of expensive biologic drugs to market. Its goal is more competition and lower drug costs for clients.
CVS Health 2025 Form 10-KTechnology and AI
The company is investing in data platforms, cloud systems, digital tools and artificial intelligence. It wants to automate work and make things easier for members, patients and doctors.
CVS Health 2025 Form 10-K
- Adjusted earnings per share (2026), full year 2026 (raised from $7.30 to $7.50)
- $7.90 to $8.10
- CVS Health Q2 2026 results press release
- Earnings per share (2026, standard accounting), full year 2026
- $6.84 to $7.04
- CVS Health Q2 2026 results press release
- Cash flow from operations, full year 2026
- At least $11.5 billion
- CVS Health Q2 2026 results press release
- Health Care Benefits adjusted operating income, full year 2026
- $5.03 billion to $5.37 billion
- CVS Health Q2 2026 results press release
- Adjusted earnings per share growth, three years starting from 2025 (through 2028)
- Mid-teens average yearly growth
- CVS Health Investor Day press release
- Deployable cash, 2026 to 2028 combined
- $55 billion to $60 billion
- CVS Health Investor Day press release
What's changing right now?
Growth is holding steady. In Q3 2026 it sold 5% more than a year earlier. The year before, quarters averaged 7%.
Its operating margin is wider than a year ago: 3¢ per sales dollar, against a loss of 3¢.
Since Oct 2026 the share price has fallen 5%, from $92.79 to $88.59.
Recently
June 30, 2026
Health Services revenue, second quarter changed to $51.8B
CVS Q2 2026 resultsDecember 31, 2025
Health Care Benefits Medical Benefit Ratio (Annual) changed to 94.2%
CVS Health Full Year 2025 Financial Results ReleaseDecember 31, 2025
Purchases of Property and Equipment (Annual) changed to $2.8B
CVS Health 2025 Form 10-K Consolidated Statements of Cash Flows
Coming up
November 4, 2026
Third-quarter 2026 results
CVS will report third-quarter results and may update its 2026 outlook on a call at 8:00 a.m. Eastern time.
CVS Health to hold third quarter 2026 earnings conference callPayments affected in 2028
Medicare bonus payments tied to 2027 star ratings
More than 69% of Aetna's Medicare Advantage members are in plans rated 4 stars or higher for 2027, down from over 81% for 2026. These ratings decide which plans get bonus payments in 2028.
Aetna 2027 Star ratings press releaseDuring 2026
Oak Street Health clinic closures
The company plans to close some existing Oak Street Health primary care clinics during 2026 and has already recorded an $83 million charge for this.
CVS Health 2025 Form 10-K
Our own estimate moved too: the base case went from $133.56 to $232.05 a share between our last two valuations. The biggest reason: Health Care Benefits Medical Benefit Ratio (Annual) moved from an unreported prior value to 94.2%, as reported in CVS Health Full Year 2025 Financial Results Release.
What could go wrong?
No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.
Medical costs higher than planned
Aetna sets most insurance prices months ahead and usually cannot raise them mid-year. If patients use more care than expected, profits drop quickly. The company expects use of care to stay high in 2026.
From the company's own filingsWould hit how much of each sale it keepsCVS Health 2025 Form 10-K
Dependence on government health programs
About 20% of revenue comes from the federal government, mostly Medicare. Changes to Medicare or Medicaid payment rates, rules or funding could cut revenue and profit.
From the company's own filingsWould hit how fast sales growCVS Health 2025 Form 10-K
Falling Medicare quality ratings
Medicare pays bonuses only to plans rated 4 stars or more. The share of Aetna members in such plans fell from 88% to over 81% in the 2026 ratings and to over 69% in the 2027 ratings, which could reduce bonus payments in 2028.
From the company's own filingsWould hit how fast sales growAetna 2027 Star ratings press release
Pressure on the pharmacy benefits business
Clients are demanding lower prices and a bigger share of drugmaker rebates. Most states and the federal government have proposed or passed laws on pharmacy benefit managers, which could limit how this business operates and earns money.
From the company's own filingsWould hit how much of each sale it keepsCVS Health 2025 Form 10-K
Lawsuits and investigations
In 2025 CVS recorded about $1.2 billion of charges from two court decisions over past practices, plus another $320 million for opioid lawsuits. More government audits or lawsuits could bring further fines or payouts.
From the company's own filingsCVS Health 2025 Form 10-K
Weak clinic results and store sales
CVS took a $5.7 billion write-down in 2025 on its health care clinics business (mainly Oak Street Health and Signify Health) and plans to close some Oak Street clinics. Shoppers spending less, or switching to grocery, discount or online stores, could also reduce store sales.
From the company's own filingsWould hit how fast sales growCVS Health 2025 Form 10-K
Federal PBM transparent pricing reforms and state legislative mandates could reduce pass-through rebate volumes across CVS Caremark.
From our researchWould hit how fast sales growFederal Trade Commission Interim Staff Report on PBMs
Ongoing medical cost inflation in hospital contracts and specialty drug therapies may outpace premium rate indexation.
From our researchWould hit how much of each sale it keepsAetna Health Care Benefits Underwriting Analysis
Is it a good business?
From 2016 to 2025 it earned between 2% and 13% on the capital invested in it, a median of 7%. Its cost of capital in the latest valuation is 6.8%; returns were above it in 6 of the 10 years.
From 2016 to 2025 it earned between -1% and 18% on its shareholders' equity, a median of 10%.
Over 10 years its operating margin ranged from 1¢ to 6¢ per sales dollar, a median of 4¢. Gross margin ran from 15¢ to 45¢.
Cost of capital 6.8%
The number of shares has held roughly steady over the past year.
It owes $48.9B more than it holds in cash, about 3.2 years of operating profit.
What might it be worth?
The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .
Today a share costs $88.59. Our put its value between $135.83 and $366.46, with $232.05 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .
Bear case, $135.83
This scenario assumes that high patient medical costs and lower prescription reimbursements keep profits subdued near recent low levels, slowing sales growth to a modest crawl.
Base case, $232.05
This scenario assumes that health insurance profit margins gradually recover from recent lows back toward historical norms, while pharmacy and clinic services deliver steady mid-single-digit sales gains.
Bull case, $366.46
This scenario assumes that healthcare insurance profits rebound strongly as medical claims normalize, while specialized pharmacy services and primary care clinics power sustained revenue expansion.
Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.
Why the gap?
The price expects less than we do.Margin of safety: 62%
At today's $88.59, the price makes sense if sales shrink about 11.5% a year. We assume they grow 4.5%. Over the last 5 years, sales grew 8.1% a year.
Or, if sales grow 4.5% as we assume, the price works with a profit margin of 2.2% (we assume 4.8%).
Keep in mind: a low price can mean investors see a risk that isn't in the filings yet. Check the Full research tab for what could go wrong.
Do you think sales will shrink?
Try your own numbersWe're moderately sure of this range: it scores 66 out of 100 on our checks. The weakest point is terminal-value dependency.
Test the assumptions
Our base value of $232.05 rests on three assumptions. Change any of them to see how the value per share responds.
- Revenue growth, 5-year average4.5%
- Operating margin4.8%
- Long-term growth rate2.5%
This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.
Base estimate
$232.05 161.9%

